N/A N=40 Randomized Single-blind Treatment

An Adjunctive Family Intervention for Individual Posttraumatic Stress Disorder Treatment

Posttraumatic Neuroses

Bottom Line

View on ClinicalTrials.gov: NCT02956434 ↗

Enrolled (actual)

Serious AEs

5.0%

Results posted

Oct 2021

Primary outcome: Primary: Clinician-Administered PTSD Scale, 5th Edition — 18.60; 21.21 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Brief Family Intervention (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: VA Office of Research and Development
Primary completion: May 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Clinician-Administered PTSD Scale, 5th Edition	18.60; 21.21	—
PRIMARY Treatment Attendance/Dropout	2; 4	—
SECONDARY Significant Others' Responses to Trauma Scale (SORTS)	22.82; 29.88	—
SECONDARY Revised Dyadic Adjustment Scale	50.60; 51.00	—

Summary

This study aims to test a brief family intervention (the BFI) to enhance individually-delivered PTSD treatment for Veterans.

Eligibility Criteria

Inclusion Criteria

Veterans must have a diagnosis of PTSD and be beginning a course of Prolonged Exposure (PE) or Cognitive Processing Therapy (CPT) at the Boston VA.
Must also have an eligible family member who is willing to participate.

Exclusion Criteria

Current diagnosis of unstable bipolar disorder, substance dependence, past or present psychosis, or organic mental disorder
Clear and current suicidal risk
Current participation in family/couples therapy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02956434). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.